MicroRNA pathways modulate polyglutamine-induced neurodegeneration

被引:210
|
作者
Bilen, Julide
Liu, Nan
Burnett, Barrington G.
Pittman, Randall N.
Bonini, Nancy M. [1 ]
机构
[1] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA
[2] Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA
关键词
D O I
10.1016/j.molcel.2006.07.030
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nine human neurodegenerative diseases are due to expansion of a CAG repeat-encoding glutamine within the open reading frame of the respective genes. Polyglutamine (polyQ) expansion confers dominant toxicity, resulting in neuronal degeneration. MicroRNAs (miRNAs) have been shown to modulate programmed cell death during development. To address whether miRNA pathways play a role in neurodegeneration, we tested whether genes critical for miRNA processing modulated toxicity induced by the spinocerebellar ataxia type 3 (SCA3) protein. These studies revealed a striking enhancement of polyQ toxicity upon reduction of miRNA processing in Drosophila and human cells. In parallel genetic screens, we identified the miRNA bantam (ban) as a potent modulator of both polyQ and tau toxicity in files. Our studies suggest that ban functions downstream of toxicity of the SCA3 protein, to prevent degeneration. These findings indicate that miRNA pathways dramatically modulate poIyQ- and tau-induced neurodegeneration, providing the foundation for new insight into therapeutics.
引用
收藏
页码:157 / 163
页数:7
相关论文
共 50 条
  • [31] Activation of p38MAPK Contributes to Expanded Polyglutamine-Induced Cytotoxicity
    Tsirigotis, Maria
    Baldwin, R. Mitchell
    Tang, Matthew Y.
    Lorimer, Ian A. J.
    Gray, Douglas A.
    PLOS ONE, 2008, 3 (05):
  • [32] Synergistic activation of AMPK prevents from polyglutamine-induced toxicity in Caenorhabditis elegans
    Gomez-Escribano, A. P.
    Bono-Yague, J.
    Garcia-Gimeno, M. A.
    Sequedo, M. D.
    Hervas, D.
    Fornes-Ferrer, V
    Torres-Sanchez, S. C.
    Millan, J. M.
    Sanz, P.
    Vazquez-Manrique, R. P.
    PHARMACOLOGICAL RESEARCH, 2020, 161
  • [33] Epimedium Polysaccharide Alleviates Polyglutamine-Induced Neurotoxicity in Caenorhabditis elegans by Reducing Oxidative Stress
    Xiang, Yanxia
    Zhang, Ju
    Li, Haifeng
    Wang, Qiangqiang
    Xiao, Lingyun
    Weng, Huandi
    Zhou, Xiaobin
    Ma, Chung Wah
    Ma, Fangli
    Hu, Minghua
    Huang, Zebo
    REJUVENATION RESEARCH, 2017, 20 (01) : 34 - 43
  • [34] Suppression of polyglutamine-induced toxicity in cell and animal models of Huntington's disease by ubiquilin
    Wang, H
    Lim, PJ
    Vogel, BE
    Monteiro, MJ
    HUMAN MOLECULAR GENETICS, 2006, 15 (06) : 1025 - 1041
  • [35] Attenuation of polyglutamine-induced toxicity by enhancement of mitochondrial OXPHOS in yeast and fly models of aging
    Ruetenik, Andrea L.
    Ocampo, Alejandro
    Ruan, Kai
    Zhu, Yi
    Li, Chong
    Zhai, R. Grace
    Barrientos, Antoni
    MICROBIAL CELL, 2016, 3 (08): : 338 - 351
  • [36] Cause or effect: misregulation of microRNA pathways in neurodegeneration
    Gascon, Eduardo
    Gao, Fen-Biao
    FRONTIERS IN NEUROSCIENCE, 2012, 6 : 1 - 10
  • [37] Suppression of heat- and polyglutamine-induced cytotoxicity by nonsteroidal anti-inflammatory drugs
    Ishihara, K
    Yamagishi, N
    Hatayama, T
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 2004, 271 (22): : 4552 - 4558
  • [38] Proteasome inhibitors suppress formation of polyglutamine-induced nuclear inclusions in cultured postmitotic neurons
    Kim, WY
    Horbinski, C
    Sigurdson, W
    Higgins, D
    JOURNAL OF NEUROCHEMISTRY, 2004, 91 (05) : 1044 - 1056
  • [39] Polyglutamine-induced neurodegeneration in SCA3 is not mitigated by non-expanded ataxin-3: Conclusions from double-transgenic mouse models
    Huebener, Jeannette
    Riess, Olaf
    NEUROBIOLOGY OF DISEASE, 2010, 38 (01) : 116 - 124
  • [40] Polyglutamine-induced ion channels: A possible mechanism for the neurotoxicity of Huntington and other CAG repeat diseases
    Hirakura, Y
    Azimov, R
    Azimova, R
    Kagan, BL
    JOURNAL OF NEUROSCIENCE RESEARCH, 2000, 60 (04) : 490 - 494